– January 1, 2004
January 1, 2004
View Issues
-
Anastrozole Update: Superior Clinical Efficacy
The arimidex, tamoxifen alone or in combination (ATAC) trial is a large-scale, international, industry-sponsored interventional, randomized study involving almost 10,000 early-stage postmenopausal breast cancer patients who were randomized to receive either anastrozole alone or in combination with tamoxifen, or tamoxifen alone. -
New Approach to Cancer of the Lip Yields Excellent Results
Controversy exists regarding the best approach to early epidermoid cancers of the lip. Various approaches have been advocated, including surgery with or without postoperative radiotherapy, and low- dose rate (LDR) brachytherapy. -
Vinorelbine-Docetaxel for Advanced Prostate Cancer: A Doublet Worth Exploring
The management of advanced, hormone-resistant prostate cancer remains challenging. -
Differences in Treatment and Outcome Between African-American and White Women with Endometrial Cancer
African-American women with endometrial cancer are significantly less likely to undergo primary surgery and have significantly shorter survival than white women with endometrial cancer. -
Additional Concerning News About EPO Treatment
In the current report, a disconcerting finding of a strikingly increased incidence of thrombosis in women with uterine cervical or vaginal carcinomas in whom erythropoietin was used to maintain hemoglobin levels at 12 g/dL was presented. -
CT Virtual Colonoscopy to Screen for Colorectal Neoplasia in Asymptomatic Adults
When analyzed using 3-dimensional methods, virtual colonoscopy achieves comparable accuracy in screening asymptomatic adults for colonic polyps as optical colonoscopy. -
Pharmacology Watch: Vioxx Might Control Postoperative Knee Pain
Oral rofecoxib (Vioxx) may have a role in controlling postoperative pain patients undergoing knee surgery.